Allergy immunotherapy is an adaptive therapy for diseases which is effectual during the treatment of allergic conjunctivitis, peanuts allergy, allergic asthma, cat allergy, stinging insect hypersensitivity, etc.. Immunotherapy is a treatment for prevention of various allergic reactions like house dust mites, grass pollens, and bee venom. Immunotherapy is increasing the dosages of the substance in which the person is allergic over some time. Increase in the allergens causes the immune system to lower the sensitivity to the substance by causing the production of an antibody that will reduce the symptoms of allergy when the person comes in contact with the substance in the future. Immunotherapy is also used to reduce the inflammation of diseases like rhinitis and asthma.
Before initiating the treatment, the immunology physician and patient identify all the trigger factors for allergy symptoms. Various skin and blood tests are performed for the confirmation of specific antigens to which the person has antibodies. Immunotherapy is usually commended only and only if the person seems to be selectively sensitive to several allergens.
COVID-19 scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the Allergy immunotherapy market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
After the launches of various new sublingual immuno-therapies in developing countries and the influence of many major players in the allergen immunotherapy market, an increase in an unmet need for novel targeted drugs which can be used to treat the disease conditions are the major factors driving the market. Sublingual allergy immunotherapy has now been clinically proven a more efficient treatment with lesser side effects as compared to alternatives available in the market currently. There is also a change observed in demographics concerning population and macroeconomic climate are other factors driving towards allergy immunotherapy market.
On the other hand, allergy immunotherapy drugs can also cause severe allergic reactions that may be fatal in some cases, and due to the limited availability of therapy in few countries it is a challenge for the allergy immunotherapy market. Additionally, less awareness about immunotherapy is limiting the growth of the sublingual allergy immunotherapy market. Also there is a lack of skilled professionals and high technological cost which is hampering the market’s development.
New product launches to flourish the market:
In January 2017, ALK Abello A/S acquired of Allergy Laboratory of Oklahoma Inc. and Crystal Labs LLC.
In October 2017, DBV Technologies entered intoR and D agreement with Stallergenes S.A. for birch allergy treatment.
In January 2017, Merck acquired BioControl which helped them strengthen their capabilities in food safety testing.
Surge in usage in hospital applications:
Improving and significantly growing healthcare infrastructure, and growing awareness about allergy immunotherapy and there is also a high prevalence of nasal allergies been observed in the recent year which will increase the demand for allergy treatment market.
Key benefits of the report:
- This study presents the analytical depiction of the global Allergy immunotherapy industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Allergy immunotherapy market share.
- The current market is quantitatively analyzed to highlight the global Allergy immunotherapy market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Allergy immunotherapy market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Allergy immunotherapy Market research report:
- What are the leading market players active in the Allergy immunotherapy market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Allergy Immunotherapy Market Report Highlights
| Aspects | Details |
 By Allergy Type |
|
 By Treatment |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | ALK Abello A/S, HAL Allergy Group, Allergy Therapeutic, Stallergenes Greer, Merck KGaA (Allergopharma), Letiand, Circassia, WOLWpharma, HolisterStier, DBV Technologies |
Loading Table Of Content...
